Biotech HOLDRs (AMEX: BBH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech HOLDRs (AMEX: BBH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Xenogenetic who wrote ()	4/13/2000 12:21:00 PM
From: bob zagorin	of 98

Robbie Stephens this morning: Raising Estimates Genentech Inc. (NYSE:DNA) F2000E EPS: $1.16 from $1.09 F2001E EPS: $1.49 from $1.47 Buy Jay Silverman, Biopharmaceuticals "Genentech reported first quarter earnings above our expectations, due to robust oncology sales," said Silverman. "In our opinion, the company is the premier biotechnology leader with a rapidly growing portfolio of marketed products, three near-term new product introductions, a deep R&D pipeline, accelerating earnings growth and a substantial cash position."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next